HPV16 E6 variants and HLA class II polymorphism among Chinese women with cervical cancer

Journal of Medical Virology

Volumn 79, Issue 4, 2007, Pages 439-446

  Wu, Yuping ^a   Liu, Benrong ^a   Lin, Wenzhi ^a   Xu, Yunping ^a   Li, Longyu ^b   Zhang, Yanling ^b   Chen, Shangwu ^a   Xu, Anlong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Maternal and Child Health Hospital of Jiangxi Province   (China)

Author keywords

Cervical cancer; HLA class II; HPV; Polymorphism; Susceptibility

Indexed keywords

HLA ANTIGEN CLASS 2; PROTEIN E6;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; NONHUMAN; POPULATION GENETICS; PROTEIN POLYMORPHISM; PROTEIN VARIANT; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS;

ALLELES; CARCINOMA; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HLA-DQ ANTIGENS; HUMANS; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33847678050     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20785     Document Type: Article

References (48)

1. Allen M, Kalantari M, Ylitalo N, Pettersson B, Hagmar B, Scheibenpflug L, Johansson B, Petterson U, Gyllensten U. 1996. HLA DQ-DR haplotype and susceptibility to cervical carcinoma: Indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens 48:32-37.
2. Apple RJ, Erlich HA, Klitz W, Manos M, Becker TM, Wheeler CM. 1994. HLA DR-DQ associations with cervical carcinoma show papillomavirus- type specificity. Nat Genet 6:157-162.
3. Baay MFQW, Koudstaal J, Hollema H, Duk JM, Burger MP, Stolz E, Herbrink P. 1996. Comprehensive study of several general and typespecific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 34:745-747.
4. Beskow AH, Josefsson AM, Gyllensten UB. 2001. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int J Cancer 93:817-822.
5. Beskow AH, Engelmark MT, Magnusson JJ, Gyllensten UB. 2005. Interaction of host and viral risk factors for development of cervical carcinoma in situ. Int J Cancer 117:690-692.
6. Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA, Sinnott P, Stern PL. 1998. HPV16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV16 E6 sequence variants. Int J Cancer 78:166-171.
7. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 87:796-802.
8. Brady CS, Duggan-Keen MF, Davidson JA, Varley JM, Stern PL. 1999. Human papillomavirus type 16 E6 variants in cervical carcinoma: Relationship to host genetic factors and clinical parameters. J Gen Virol 80:3233-3240.
9. Cheng G, Icenogle JP, Kirnbauer R, Hubbert NL, St Louis ME, Han C, Svare EI, Kjaer SK, Lowy DR, Schiller JT. 1995. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J Infect Dis 172:1584-1587.
10. Cuzick J, Terry G, Ho L, Monaghan J, Lopes A, Clarkson P, Duncan I. 2000. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 82:1348-1352.
11. de Boer MA, Peters LAW, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova ES, Kolkman-Uljee S, Fleuren GJ. 2004. Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 94:488-494.
12. Dean J, Dean A, Burton J. 1990. Public domain software for epidemiology and disease surveillance. WHO AIDS Series.
13. Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Bartholomew JS, Young LS. 1995. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1:464-470.
14. Ellis JRM, Etherington I, Galloway D, Luesley D, Young LS. 1997. Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16. Lancet 349:1069-1070.
15. Eriksson A, Herron JR, Yamada T, Wheeler CM. 1999. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J Gen Virol 80:595-600.
16. Etherington IJ, Ellis JR, Luesley DM, Moffitt DD, Young LS. 1999. Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol Oncol 72:56-59.
17. Fu Y, Liu Z, Lin J, Chen W, Jia Z, Pan D, Xu A. 2003. Extensive polymorphism and different evolutionary patterns of intron 2 were identified in the HLA-DQB1 gene. Immunogenetics 54:761-766.
18. Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M. 2003. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 12:477-484.
19. Helland A, Borresen AL, Kristensen G, Ronningen KS. 1994. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: Relationship to human papillomavirus infection and prognosis. Cancer Epidemiol Biomarkers Prev 3:479-486.
20. Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M. 1998. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 7:1035-1041.
21. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318.
22. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL, Bernard HU. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 29:1765-1772.
23. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67:6413-6423.
24. Jia ZJ, Pan DJ, Fu YG, Chen WM, Liu ZH, Lin JH, Zhu YF, Chen RX, Fu ZY, Zhou DM, Xu AL. 2001. HLA-DRB1 gene polymorphism of Naxi ethnic group of Yunnan Province, China and its ethnological evolution analysis. Yi Chuan Xue Bao 28:1107-1115.
25. Kotsch K, Wehling J, Blasczyk R. 1999. Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: Sequencing based typing of HLA DRB genes. Tissue Antigens 53:486-497.
26. Liu Z, Lin J, Fu Z, Pan D, Xu A. 2001. A Sequence based Method for HLA-DPB1 Genotyping. Acta Scientiarum Naturalium Universitatis Sun Yat-sen 40:83-87.
27. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler CM, Singer A. 1996. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69:364-368.
28. Luxton J, Mant C, Greenwood B, Derias N, Nath R, Shepherd P, Cason J. 2000. HPV16 E6 oncogene variants in women with cervical intraepithelial neoplasia. J Med Virol 60:337-341.
29. Matsumoto K, Yasugi T, Nakagawa S, Okubo M, Hirata R, Maeda H, Yoshikawa H, Taketani Y. 2003. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer 106:919-922.
30. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M. 1999. Uniform distribution of HPV E6 and E7 variants in patients with normal histology, cervical intraepithelial neoplasia and cervical cancer. Int J Cancer 82:203-207.
31. Schneider S, Roessli D, Excoffier L. 2000. Arlequin Version 2.000: A Software for Population Genetics Data Analysis. Genera, Switzerland: Genetics and Biometry Laboratory, University of Geneva.
32. Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG. 1985. Human papillomavirus Type 16 DNA sequence. Virology 145:181-185.
33. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. 1996. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 70:6987-6993.
34. Svejgaard A, Ryder LP. 1994. HLA and disease associations: Detecting the strongest associati8-on. Tissue Antigens 43:18-27.
35. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellate G, Greggi S, Piccoli R, Pilotti S, Stefanen B, De Palo G, Franceschi S, Buonaguro FM. 2004. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 74:117-126.
36. Versluis LF, Rozemuller E, Tonks S, Marsh SG, Bouwens AG, Bodmer JG, Tilanus MGJ. 1993. High-resolution HLA DPB typing based upon computerized analysis of data obtained by fluorescent sequencing of the amplified polymorphic exon 2. Hum Immunol 38:277-283.
37. Wu Y, Chen Y, Li L, Yu G, He Y, Zhang Y. 2006a. Analysis of mutations in the E6/E7 oncogenes and Ll gene of human papillomavirus 16 cervical cancer isolates from China. J Gen Virol 87:1181-1188.
38. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. 2006b. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35:264-269.
39. Wu Y, Chen Y, Li L, Cao Y, Liu Z, Liu B, Du Z, Zhang Y, Chen S, Lin Z, Xu A. 2006c. Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women. Int J Cancer 118:3006-3011.
40. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802.
41. Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Hawes SE, Surawicz C, Goldbaum G, Holmes KK, Kiviat NB. 1998. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 58:3839-3844.
42. Xiang YB, Gao YT, Wang TJ. 1999. Application and comparison of Meta and pooled analysis in the study of cancer epidemiology. Chin J Oncol 21:354-358.
43. Yamada T, Wheeler CM, Halpern AL, Stewart AM, Hildesheim A, Jenison SA. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2 and L1 coding segments. J Virol 69:7743-7753.
44. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol 71:2463-2472.
45. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. 1998a. Risk of cervical cancer and geographical variations of human papilloma-virus 16 E6 polymorphisms. Lancet 352:1441-1442.
46. Zehbe I, Wilander E, Delius H, Tommasino M. 1998b. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833.
47. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Marongiu A, Gissmann L, Wilander E, Tommasino M. 2001. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94:711-716.
48. Zehbe I, Mytilineos J, Wikstrom I, Henriksen R, Edler L, Tommasino M. 2003. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum Immunol 64:538-542.